BRAF and melanoma: The IdyllaTM BRAF Mutation Test, CE IVD, on the IdyllaTM platform (Biocartis, Mechelen, Belgium) was successfully launched for the fast and accurate detection of BRAF V600 mutations in melanoma patients, directly on FFPE samples [20, 21].